Overexpression of ZEB2 in peritumoral liver tissue correlates with favorable survival after curative resection of hepatocellular carcinoma

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Cai, Mu Yan ^a,b   Luo, Rong Zhen ^a,b   Chen, Jie Wei ^a,b   Pei, Xiao Qing ^b   Lu, Jia Bin ^a,b   Hou, Jing Hui ^a,b   Yun, Jing Ping ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; ZINC FINGER E BOX BINDING HOMEOBOX 2; ZINC FINGER PROTEIN; HOMEODOMAIN PROTEIN; REPRESSOR PROTEIN; ZEB2 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER INHIBITION; CANCER INVASION; CANCER PROGNOSIS; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CELL NUCLEUS; CYTOPLASM; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PERITUMORAL LIVER TISSUE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SURVIVAL TIME; TISSUE MICROARRAY; TUMOR DIFFERENTIATION; TUMOR VOLUME; WESTERN BLOTTING; BIOSYNTHESIS; DNA MICROARRAY; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; LIVER TUMOR; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC;

ADULT; CARCINOMA, HEPATOCELLULAR; CYTOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; REPRESSOR PROTEINS; ROC CURVE;

EID: 84863267323     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032838     Document Type: Article

References (34)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, et al. (2007) Cancer statistics, 2007. CA Cancer J Clin 57: 43-66.
2. Hsu YC, Fu HH, Jeng YM, Lee PH, Yang SD, (2006) Proline-directed protein kinase FA is a powerful and independent prognostic predictor for progression and patient survival of hepatocellular carcinoma. J Clin Oncol 24: 3780-3788.
3. Tang ZY, Ye SL, Liu YK, Qin LX, Sun HC, et al. (2004) A decade's studies on metastasis of hepatocellular carcinoma. J Cancer Res Clin Oncol 130: 187-196.
4. Yang Y, Nagano H, Ota H, Morimoto O, Nakamura M, et al. (2007) Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection. Surgery 141: 196-202.
5. Zhu XD, Zhang JB, Zhuang PY, Zhu HG, Zhang W, et al. (2008) High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. J Clin Oncol 26: 2707-2716.
6. Mann CD, Neal CP, Garcea G, Manson MM, Dennison AR, et al. (2007) Prognostic molecular markers in hepatocellular carcinoma: a systematic review. Eur J Cancer 43: 979-992.
7. Llovet JM, Bruix J, (2008) Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 48 (Suppl 1): S20-37.
8. Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, et al. (2008) Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 100: 698-711.
9. Remacle JE, Kraft H, Lerchner W, Wuytens G, Collart C, et al. (1999) New mode of DNA binding of multi-zinc finger transcription factors: deltaEF1 family members bind with two hands to two target sites. EMBO J 18: 5073-5084.
10. Verschueren K, Remacle JE, Collart C, Kraft H, Baker BS, et al. (1999) SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5′-CACCT sequences in candidate target genes. J Biol Chem 274: 20489-20498.
11. Postigo AA, Depp JL, Taylor JJ, Kroll KL, (2003) Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins. EMBO J 22: 2453-2462.
12. Lin SY, Elledge SJ, (2003) Multiple tumor suppressor pathways negatively regulate telomerase. Cell 113: 881-889.
13. Ozturk N, Erdal E, Mumcuoglu M, Akcali KC, Yalcin O, et al. (2006) Reprogramming of replicative senescence in hepatocellular carcinoma-derived cells. Proc Natl Acad Sci U S A 103: 2178-2183.
14. Elloul S, Elstrand MB, Nesland JM, Trope CG, Kvalheim G, et al. (2005) Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer 103: 1631-1643.
15. Krishnamachary B, Zagzag D, Nagasawa H, Rainey K, Okuyama H, et al. (2006) Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res 66: 2725-2731.
16. Sayan AE, Griffiths TR, Pal R, Browne GJ, Ruddick A, et al. (2009) SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer. Proc Natl Acad Sci U S A 106: 14884-14889.
17. Maeda G, Chiba T, Okazaki M, Satoh T, Taya Y, et al. (2005) Expression of SIP1 in oral squamous cell carcinomas: implications for E-cadherin expression and tumor progression. Int J Oncol 27: 1535-1541.
18. Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, et al. (2007) Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 25: 2586-2593.
19. Sobin LH, Fleming ID, (1997) TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 80: 1803-1804.
20. Cai MY, Tong ZT, Zheng F, Liao YJ, Wang Y, et al. (2011) EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies. Gut 60: 967-976.
21. Abubaker J, Bavi P, Al-Haqawi W, Jehan Z, Munkarah A, et al. (2009) PIK3CA alterations in Middle Eastern ovarian cancers. Mol Cancer 8: 51.
22. Zlobec I, Steele R, Terracciano L, Jass JR, Lugli A, (2007) Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer. J Clin Pathol 60: 1112-1116.
23. Cai MY, Zhang B, He WP, Yang GF, Rao HL, et al. (2010) Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinoma. Cancer Sci 101: 1543-1549.
24. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, et al. (2001) The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 7: 1267-1278.
25. Imamichi Y, Konig A, Gress T, Menke A, (2007) Collagen type I-induced Smad-interacting protein 1 expression downregulates E-cadherin in pancreatic cancer. Oncogene 26: 2381-2385.
26. Miyoshi A, Kitajima Y, Sumi K, Sato K, Hagiwara A, et al. (2004) Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells. Br J Cancer 90: 1265-1273.
27. Oztas E, Avci ME, Ozcan A, Sayan AE, Tulchinsky E, et al. (2010) Novel monoclonal antibodies detect Smad-interacting protein 1 (SIP1) in the cytoplasm of human cells from multiple tumor tissue arrays. Exp Mol Pathol 89: 182-189.
28. Yoshida J, Horiuchi A, Kikuchi N, Hayashi A, Osada R, et al. (2009) Changes in the expression of E-cadherin repressors, Snail, Slug, SIP1, and Twist, in the development and progression of ovarian carcinoma: the important role of Snail in ovarian tumorigenesis and progression. Med Mol Morphol 42: 82-91.
29. Mejlvang J, Kriajevska M, Vandewalle C, Chernova T, Sayan AE, et al. (2007) Direct repression of cyclin D1 by SIP1 attenuates cell cycle progression in cells undergoing an epithelial mesenchymal transition. Mol Biol Cell 18: 4615-4624.
30. Acun T, Oztas E, Yagci T, Yakicier MC, (2011) SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation. BMC Cancer 11: 223.
31. Massague J, (2008) TGFbeta in Cancer. Cell 134: 215-230.
32. Postigo AA, (2003) Opposing functions of ZEB proteins in the regulation of the TGFbeta/BMP signaling pathway. EMBO J 22: 2443-2452.
33. Ezaki T, Ikegami T, Ishida T, Aimitsu S, Mori M, et al. (2003) Significance of thymidine phosphorylase in HCC with chronic liver disease for long-term postoperative recurrence. J Surg Oncol 83: 173-179; discussion 179.
34. Okamoto M, Utsunomiya T, Wakiyama S, Hashimoto M, Fukuzawa K, et al. (2006) Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients. Ann Surg Oncol 13: 947-954.